MIIM
EVH icon

Mesirow Institutional Investment Management’s Evolent Health EVH Stock Holding History

Mesirow Institutional Investment Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$7.9M Buy
701,927
+282,509
+67% +$4.96M 0.61% 79
2024
Q3 		$11.9M Buy
+419,418
New +$10.8M 0.91% 67

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Mesirow Institutional Investment Management's EVH Position: Q4 2024 in Review

Mesirow Institutional Investment Management increased its Evolent Health (EVH) stake by 67% in Q4 2024, buying an estimated $4.96M and bringing the position to 701,927 shares worth $7.9M. The position accounts for 0.61% of the portfolio, ranked #79.

Mesirow Institutional Investment Management first reported a position in EVH in Q3 2024 and has held it in 2 quarters since. The position peaked at $11.9M in Q3 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q4 2024.

  • Mesirow Institutional Investment Management held 701,927 shares of Evolent Health worth $7.9M as of Q4 2024.
  • Mesirow Institutional Investment Management bought 282,509 Evolent Health shares in Q4 2024, an estimated $4.96M.
  • Evolent Health made up 0.61% of Mesirow Institutional Investment Management's portfolio in Q4 2024, its #79 holding.
  • Mesirow Institutional Investment Management first reported a position in Evolent Health in Q3 2024 and has held it in 2 quarters since.
  • Mesirow Institutional Investment Management's Evolent Health position peaked at $11.9M in Q3 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q4 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.